Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Colon or Rectum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06171854
What this trial is testing

CaBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.

Who this might be right for
Refractory Colorectal Adenocarcinoma
University of Campania Luigi Vanvitelli 33
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT01442935
What this trial is testing

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

Who this might be right for
Colorectal Cancer
UNICANCER 256
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Study completedNCT01442649
What this trial is testing

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Who this might be right for
Colorectal Cancer
UNICANCER 133
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Large-scale testing (Phase 3)UnknownNCT00182715
What this trial is testing

Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Velindre NHS Trust 2,421
Early research (Phase 1)Study completedNCT00023933
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00016978
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)Looking for participantsNCT07020117
What this trial is testing

[225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Who this might be right for
Urothelial Carcinoma BladderTriple Negative Breast Cancer (TNBC)Hormone Receptor Positive Breast Adenocarcinoma+4 more
Aktis Oncology, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00541125
What this trial is testing

G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 20
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Study completedNCT00016952
What this trial is testing

Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 19
Not applicableWithdrawnNCT04148378
What this trial is testing

A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+3 more
ProgenaBiome
Testing effectiveness (Phase 2)Study completedNCT00005085
What this trial is testing

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Early research (Phase 1)WithdrawnNCT04632199
What this trial is testing

Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal Cancer
Ipsen
Testing effectiveness (Phase 2)Study completedNCT00098787
What this trial is testing

Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 247
Testing effectiveness (Phase 2)Study completedNCT00655499
What this trial is testing

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 65
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Testing effectiveness (Phase 2)WithdrawnNCT06575725
What this trial is testing

Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer

Who this might be right for
Advanced Colon AdenocarcinomaAdvanced Colorectal AdenocarcinomaAdvanced Rectal Adenocarcinoma+9 more
City of Hope Medical Center
Next Page